Protalix BioTherapeutics ... (PLX)
AMEX: PLX
· Real-Time Price · USD
1.48
-0.04 (-2.63%)
At close: Aug 15, 2025, 3:59 PM
1.50
1.35%
After-hours: Aug 15, 2025, 05:59 PM EDT
Protalix BioTherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.11M | 18.22M | 17.96M | 13.47M | 3.75M | 10.49M | 10.35M | 35.08M | 9.59M | 8.62M | 14.18M | 8.75M | 16.09M | 8.55M | 12.05M | 6.43M | 11.32M |
Cost of Revenue | 8.18M | 3.89M | 8.38M | 9.46M | 2.6M | 8.86M | 4.89M | 6.15M | 3.08M | 2.4M | 7.07M | 4.09M | 6.03M | 3.15M | 3.7M | 4.73M | 4.76M |
Gross Profit | 1.93M | 14.33M | 9.58M | 4.02M | 1.15M | 1.63M | 5.45M | 28.93M | 6.5M | 6.22M | 7.11M | 4.67M | 10.05M | 5.4M | 8.35M | 1.69M | 6.55M |
Operating Income | -4.14M | 7.21M | 3.99M | -2.43M | -4.86M | -5.62M | -1.89M | 20.42M | -2.46M | -2.5M | -3.13M | -5.52M | -1.87M | -5.71M | -1.89M | -9.17M | -3.71M |
Interest Income | 419K | 113K | 151K | 522K | 513K | -37K | 628K | 531K | 172K | n/a | 197K | 813K | 202K | n/a | 96K | 128K | 335K |
Pretax Income | -3.73M | 7.32M | 3.84M | -2.27M | -4.73M | -6.43M | -1.72M | 19.65M | -2.94M | -3.21M | -3.57M | -5.33M | -2.29M | -6.67M | -4.2M | -11.24M | -5.47M |
Net Income | -3.62M | 6.49M | 3.24M | -2.2M | -4.59M | -6.04M | -1.85M | 19.34M | -3.13M | -3.74M | -3.57M | -5.33M | -2.29M | -6.67M | -4.2M | -11.24M | -5.47M |
Selling & General & Admin | 2.6M | 3M | 2.6M | 3.48M | 3.12M | 4.14M | 3.67M | 4.03M | 3.12M | 3.1M | 2.85M | 2.61M | 3.15M | 3.47M | 2.95M | 3.17M | 3.14M |
Research & Development | 3.48M | 4.12M | 3M | 2.96M | 2.89M | 3.1M | 3.67M | 4.47M | 5.85M | 5.62M | 7.39M | 7.58M | 8.77M | 7.64M | 7.28M | 7.69M | 7.12M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51K |
Operating Expenses | 6.08M | 7.12M | 5.59M | 6.45M | 6M | 7.25M | 7.34M | 8.51M | 8.96M | 8.71M | 10.23M | 10.19M | 11.92M | 11.11M | 10.24M | 10.86M | 10.26M |
Interest Expense | 6K | 6K | 299K | 367K | 390K | 774K | 460K | 1.3M | 649K | 715K | 639K | 623K | 618K | 1.74M | 2.41M | 2.2M | 2.16M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 10.11M | 10.17M | 15.07M | 5.07M | 25.29M | 8.81M | 3.38M | 9.03M | n/a | 4.51M | 3.24M | 4.51M |
Cost & Expenses | 14.26M | 11.01M | 13.97M | 15.9M | 8.6M | 16.1M | 12.23M | 14.65M | 12.05M | 11.11M | 17.31M | 14.28M | 17.95M | 14.26M | 13.94M | 15.59M | 15.03M |
Income Tax Expense | -113K | 822K | 607K | -69K | -138K | -382K | 133K | 308K | 195K | 530K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.61M | 73.55M | 73.55M | 73.31M | 73.04M | 72.95M | 72.28M | 67.16M | 57.48M | 51.34M | 49.5M | 47.33M | 45.72M | 45.28M | 45.56M | 45.44M | 39.93M |
Shares Outstanding (Diluted) | 76.61M | 81.06M | 81.22M | 73.31M | 73.04M | 72.95M | 83.78M | 83.2M | 57.48M | 51.34M | 49.5M | 47.33M | 45.84M | 45.56M | 45.56M | 45.44M | 39.93M |
EPS (Basic) | -0.05 | 0.04 | 0.04 | -0.03 | -0.06 | -0.08 | -0.03 | 0.29 | -0.05 | -0.07 | -0.07 | -0.11 | -0.05 | -0.15 | -0.09 | -0.25 | -0.14 |
EPS (Diluted) | -0.05 | 0.04 | 0.03 | -0.03 | -0.06 | -0.08 | -0.02 | 0.21 | -0.05 | -0.07 | -0.07 | -0.11 | -0.05 | -0.15 | -0.09 | -0.25 | -0.14 |
EBITDA | -3.38M | 7.66M | 4.47M | -1.59M | -4.02M | -5.34M | -954K | 21.25M | -2.01M | -2.29M | -2.65M | -4.44M | -1.4M | -5.5M | -1.5M | -8.75M | -3.03M |
EBIT | -3.73M | 7.32M | 4.14M | -1.91M | -4.34M | -5.65M | -1.26M | 20.95M | -2.29M | -2.56M | -2.93M | -4.71M | -1.67M | -5.76M | -1.79M | -9.04M | -3.32M |
Depreciation & Amortization | 346K | 334K | 329K | 319K | 322K | 313K | 305K | 293K | 280K | 275K | 273K | 268K | 270K | 259K | 285K | 288K | 286K |